| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
-Mediated Mechanism
From the Department of Molecular Biomedical Sciences,* College of Veterinary Medicine, and the Department of Molecular and Environmental Toxicology, North Carolina State University, Raleigh, North Carolina
 |
Abstract |
|---|
 Top Abstract Materials and MethodsResultsDiscussionReferences |
|---|
, 
, 
, 
, 
, and 
were constitutively expressed in NHBE cells while PKCß, 
, and µ were PMA-inducible. PKC was the only isoform to translocate from cytoplasm to membrane in response to HNE. Inhibition of PKC attenuated HNE-mediated mucin secretion. The results suggest HNE stimulation of mucin release by human airway epithelial cells involves intracellular activation of PKC, specifically the isoform.
In this study, well-differentiated primary normal human tracheobronchial epithelial (NHBE) cells maintained in vitro in air/liquid interface were exposed to HNE, and the secretory response assessed. Elastase proved to be a potent mucin secretagogue for NHBE cells, eliciting a robust (greater than twofold) increase in mucin secretion within 15 minutes. The mucin gene products released included those of MUC5AC and MUC5B, but not of MUC2. The mechanism appeared to involve activation of protein kinase C (PKC), as HNE exposure rapidly provoked phosphorylation of MARCKS (myristoylated alanine-rich C kinase substrate) protein, a cellular substrate of PKC, and the mucin secretory response to HNE was attenuated by two different PKC inhibitors. Additional studies provided compelling evidence that PKC is the specific PKC isoform involved in the secretory pathway.
|
Materials and Methods |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
All chemicals were of analytical grade or higher. NHBE cells, bronchial epithelial basal medium, and supplements for air/liquid interface cell cultures were purchased from Cambrex (San Diego, CA). Endotoxin-free HNE purified from human sputum was purchased from Elastin Products Company (EPC, Owensville, MO). Cytotoxicity was evaluated with CytoTox 96 nonradioactive cytotoxicity assay kits obtained from Promega Corp. (Madison, WI). A specific HNE substrate, MeO-SUC-AL-AL-PRO-VAL-PNA, and an HNE inhibitor, chloromethyl ketone-modified tetrapeptide (CMK), also were purchased from EPC and the HNE inhibitor elastatinal was obtained from Calbiochem (La Jolla, CA). 17Q2 pan mucin antibody was purchased from Babco (Richmond, CA) and anti-MUC5AC (45M1) was purchased from Neomarkers (Fremont, CA). A monoclonal antibody (11C1) against human MUC5B was generously provided by Dr. Reen Wu, University of California at Davis, Davis, CA. The epitope for this antibody, which was generated from the secreted mucin of well-differentiated airway epithelial cells, is not known, but by immunohistochemical staining and Western blot analysis, it appears to recognize the MUC5B peptide. A monoclonal antibody that cross reacts with human MUC2, raised against the guinea pig 522-bp gene sequence analogous to the human D4 domain located in the carboxy-terminal region of the Muc2 gene sequence established previously in our laboratory, was used to detect MUC2 mucins.20
An ImmunoPure (G) IgG purification kit used for purification of antibodies for enzyme-linked immunosorbent assay (ELISA) was from Pierce (Rockford, IL). For Western blot analysis of PKC isoforms expressed in NHBE cells, a PKC sampler kit and E-cadherin antibody were obtained from BD Biosciences (San Jose, CA). Goat anti-PKC and mouse anti--tubulin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies against phosphorylated (ser) PKC substrate and phosphorylated MARCKS were from Cell Signaling Technology (Beverly, MA). Horseradish peroxidase-conjugated goat anti-mouse IgG and donkey anti-goat IgG also were purchased from Santa Cruz Biotechnology. Horseradish peroxidase-conjugated goat anti-rabbit IgG was purchased from Upstate Biotechnology (Lake Placid, NY). Enhanced chemiluminescence development kits and Hyperfilm were from Amersham Pharmacia Biotech (Piscataway, NJ). All PKC-related inhibitors (ie, calphostin C, bisindoylmaleimide, PKC epsilon and zeta inhibitor peptides, rottlerin) were purchased from Calbiochem. A PepTag assay for nonradioactive detection of PKC activity was purchased from Promega. Other chemical reagents were purchased from Sigma-Aldrich (St. Louis, MO). Transwell-Clear culture inserts and high-binding 96-well assay plates were purchased from Corning Inc. (Corning, NY).
Epithelial Cell Culture
Primary cultures of NHBE cells were established using an air/liquid interface cell culture system described previously.21 Briefly, NHBE cells were expanded once and cells collected and frozen in liquid nitrogen (referred to as passage-2 cells). Air/liquid interface cultures of NHBE cells were established on Transwell-Clear culture inserts thin-coated with rat-tail type I collagen. The basic medium used for NHBE cells was a 1:1 mixture of bronchial epithelial basal medium and high glucose (4.5 g/L) Dulbecco’s modified Eagle’s medium. The complete medium was composed of basic medium containing a final concentration of 0.5 ng/ml human recombinant epidermal growth factor, 0.5 µg/ml hydrocortisone, 5 µg/ml insulin, 10 µg/ml transferrin, 0.5 µg/ml epinephrine, 6.5 ng/ml triiodothyronine, 50 µg/ml gentamicin, and 50 ng/ml amphotericin-B. In addition, the media contained 0.13 mg/ml bovine pituitary extract made according to the protocol of Bertolero and colleagues,22 5 x 10–8 mol/L all-trans retinoic acid, 1.5 µg/ml bovine serum albumin, and 20 U/ml nystatin.
Frozen NHBE cells were recovered and seeded at a density of 
2 x 104
cells/cm2
onto the apical surface of the inserts. Media were changed the next day, then every other day until the cells reached 90% confluence. At this point, the air/liquid interface was established by removing the apical media, whereas basolateral media were changed daily for up to 21 days. A mucin phenotype was observed at 14 days in culture (7 days in air-liquid interface culture) and cilia were apparent by 18 days in culture. Mucin secretion reached maximal levels at 18 days in culture, so cells cultured for 18 to 21 days were used for the experiments described below.
Exposure of Cells to HNE
HNE stock was made as 10 mg/ml (339 µmol/L) in a 1:1 mixture of glycerol and 0.02 mol/L NaOAc, pH 5.0. The stock was diluted into the culture medium to the final concentration indicated. In all studies, the above solvent appropriately diluted was used as a negative control.
Quantification of Mucin Secretion
NHBE cells were exposed to HNE from both apical and basolateral sides for 15 minutes (unless otherwise indicated). At the end of each treatment, apical medium containing the secreted mucin was collected and quantified. Briefly, 0.25 ml of media containing secreted mucin was collected, 0.5 ml of 1 mmol/L dithiothreitol in phosphate-buffered saline (PBS) was added into each well, and the plates were gently agitated and allowed to stand for 3 minutes before the dithiothreitol/PBS plus mucin was collected in the same tube. Finally, 0.5 ml of 10 µmol/L CMK in PBS was added and collected the same way. Approximately 1.25 ml of the collected mucin mixture with dithiothreitol and CMK was centrifuged at 8000 rpm for 5 minutes to remove cell debris, and then collected in a fresh tube. Phenylmethyl sulfonyl fluoride was added to a final concentration of 1 mmol/L.
Baseline and treatment mucin secretions were collected from each culture plate. Baseline mucin secretion was collected to normalize variations from well to well, and to control for possible release of mucin in response to the stress of media change or washing. After the baseline mucin secretion sample was collected, the cells were rested overnight and exposed to test agents the next day for indicated periods of time. Mucin samples were quantified using specific ELISA methods. Firstly, total mucin was quantified by a double-sandwich ELISA using a pan-mucin antibody, 17Q2, that cross reacts with a carbohydrate epitope on human mucins, as described previously.21 Additional studies were performed using ELISAs for secreted protein products of the mucin genes MUC5AC, MUC5B, and MUC2 to determine which mucin gene products were being released on exposure to HNE. MUC5AC was measured via ELISA as described by Takeyama and colleagues23 using the 45M1 antibody. MUC5B protein was assayed via a standard double-sandwich ELISA method using the 11C1 monoclonal antibody against MUC5B provided by Dr. Reen Wu, University of California, Davis, Davis, CA, as described previously.24,25 The MUC2 gene product was quantified by modification of an ELISA as described previously.20
Assay of HNE Activity
HNE activity assays were performed following the manufacturer’s protocol (EPC). HNE substrate was prepared in substrate buffer (Tris-NaCl buffer: 0.1 mol/L Tris, pH 7.5, containing 0.5 mol/L NaCl and 0.01% Na3N). Briefly, 3 ml of substrate solution at 25°C was added to test tubes, 1.0 µg of HNE then was added, and the developed color was read immediately and continuously thereafter at 1 minute intervals. Elastase activity was reflected by the rate increase in absorbance in time units (minutes). Color development was read at 410 nm on a spectrophotometer UV160U (Shimadzu, Kyoto, Japan). The specific activity of HNE was expressed as U/mg, and results expressed as percentage of activity of native HNE for each treatment.
Effects of HNE Enzymatic Inhibition
Effects of enzymatic inhibition of HNE were investigated using three different elastase inhibitors: 1) elastatinal, a natural HNE inhibitor produced by Actinomycetes;26
2) CMK, a synthetic tetrapeptide;27
and 3) 1-antitrypsin (1-AT), a physiological HNE inhibitor.28
The inhibitors were added directly to HNE, incubated for 15 minutes at 37°C, and then added directly to the cells for another 15 minutes. At the end of this exposure, secreted mucin was collected and quantified as described above.
To determine whether HNE enzymatic activity was directly required for stimulated mucin secretion, or if a secondary product(s) released by NHBE cells after exposure to HNE could be involved in the secretory response, NHBE cells were exposed to HNE (or vehicle) for 5 minutes. After exposure, the conditioned medium was collected and treated with 5 µmol/L of the HNE enzymatic inhibitor, 1-AT, for 15 minutes, at which time this 1-AT-treated medium was added to a new set of NHBE cells and effects on mucin secretion quantified as described above.
Effects of PKC Inhibition
The PKC inhibitors, bisindolylmaleimide I (10, 100, 1000 nmol/L)29 or calphostin C (5, 50, 500 nmol/L)30 were used to determine PKC involvement in HNE-induced mucin secretion. NHBE cells were preincubated with these agents (or vehicle control) for 15 minutes, then HNE was added for another 15 minutes before mucin secretion was quantified as described above.
PKC Activity Assay
PKC activity in NHBE cells after exposure to HNE was assessed using a PepTag assay for nonradioactive detection of PKC (following the manufacturer’s protocol). Briefly, 10 µg of protein extracted from each treatment of NHBE cells was added into the PKC reaction buffer (20 mmol/L HEPES, pH 7.4, 1.3 mmol/L CaCl2, 1 mmol/L dithiothreitol, 10 mmol/L MgCl2, 1 mmol/L ATP) containing 1 mg/ml phosphatidylserine and PepTag C1 PKC substrate peptide (P-L-S-R-T-L-S-V-A-A-K) conjugated with fluorescent dye, and incubated for 30 minutes at 30°C. The reaction was stopped by boiling at 100°C for 10 minutes. Reaction mixtures were separated on 0.8% agarose gels and proteins quantified by Labworks image acquisition and analysis software (UVP Bioimaging System, Upland, CA). Phosphorylation of MARCKS was detected by Western blot using an antibody against phophospecific-MARCKS.
PKC Isoform Analysis
After treatments, NHBE cells were washed with ice-cold PBS twice and then scraped into lysis buffer (50 mmol/L Tris, pH 7.5, 1 mmol/L ethylenediamine tetraacetic acid, 100 mmol/L NaCl, 1 mmol/L phenylmethyl sulfonyl fluoride) using a rubber policemen. The collected cells were lysed by sonication. For separation of cytosolic and membrane fractions, the lysates were spun at 400,000 x g in a Sorvall Discovery 100S ultracentrifuge (Sorvall, Inc. Newtown, CT) for 1 hour. The supernatant was reserved as the cytosolic sample. The pellet was resuspended in the same lysis buffer containing 0.05% Triton-100, dissolved by sonication, and incubated on ice for 30 minutes. After incubation, the same ultracentrifugation as described above was performed on the pellet mixture, and the supernatant separated from the pellet mixture was reserved as the membrane fraction. For preparation of whole cell crude lysates, the disrupted cellular mixture was centrifuged at 15,000 rpm in an Eppendorf 5417R centrifuge (Eppendorf Corp., Hamburg, Germany) for 1 hour at 4°C. The supernatant was collected as the whole crude NHBE cell lysate.
The protein concentration of cell lysate samples was quantified by a Bradford assay (Bio-Rad Laboratories, Hercules, CA). Each sample was boiled in 2x sodium dodecyl sulfate-polyacrylamide gel electrophoresis sample buffer for 10 minutes, loaded on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels, and transferred to a polyvinylidene difluoride membrane (Micron Separation Inc., Westborough, MA). After blocking with 5% skim milk, the antigen was captured by the specific PKC antibody and further amplified by binding to horseradish peroxidase-conjugated anti-mouse or anti-rabbit antibodies. Anti--tubulin and E-cadherin antibodies were used for cytosolic and membrane controls, respectively, for each sample. Final development was accomplished by the enhanced chemiluminescence method. The amount of each PKC isoform was analyzed by Labworks image acquisition and analysis software.
Effects of PKC Isoform-Specific Inhibitors on HNE-Induced PKC Activation and Mucin Secretion
Because the studies above indicated that PKC was the only isoform to translocate to membranes in response to HNE, additional studies were performed with rottlerin, an inhibitor of PKC and 
.31
(Because PKC was not expressed in NHBE cells under basal or stimulated conditions, rottlerin is referred to below as a specific inhibitor of PKC). Rottlerin has the following potency against PKC isoforms: PKC (IC50 = 3 to 6 µmol/L); PKC (IC50 = 50 µmol/L); PKC, PKCß, and PKC 
(IC50 = 30 to 42 µmol/L); PKC, PKC, and PKC (IC50 = 80 to 100 µmol/L). It also can inhibit CaM kinase III (IC50 = 5.3 µmol/L).31,32
Cells were preincubated with rottlerin (1.5 µmol/L; IC50 = 3 to 6 µmol/L) for 20 minutes before exposure to HNE, and effects on PKC activity [using detection of phosphorylated (ser) PKC substrate] and on HNE-induced mucin secretion were assessed. As additional controls, the potential role of other PKC isoforms present in these cells was assessed: cells were exposed to the following specific inhibitors for 15 minutes before exposure to HNE and assay for mucin secretion: The PKC/ß inhibitor, Gö 6976 (10 nmol/L; IC50 = 2 6 nmol/L);29
a PKC peptide inhibitor (50 µmol/L; Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu; IC50 = 10 µmol/L);33
or a PKC peptide inhibitor (3 300 µmol/L; Glu-Ala-Val-Ser-Leu-Lys-Pro-Thr; IC50 = 80.3 µmol/L).34,35
Statistical Analysis
Data were expressed as the ratio of treatment to the corresponding vehicle control. Results were evaluated using one-way analysis of variance with Bonferroni posttest correction for multiple comparisons.36 A P value of <0.05 was considered significant.
|
Results |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
All reagents used were tested for cytotoxicity using a Promega Cytotox 96 nonradioactive cytotoxicity assay kit according to the manufacturer’s instructions. The data were expressed as the ratio of released lactate dehydrogenase to total lactate dehydrogenase. Released lactate dehydrogenase never exceeded 10% of total lactate dehydrogenase (data not shown) in any of the experiments below.
Effects of HNE on Mucin Secretion
As illustrated in Figure 1
, HNE stimulated mucin secretion by NHBE cells. Maximal mucin secretion was elicited after 15 minutes exposure to HNE (Figure 1A)
so this time point was chosen for additional experiments. HNE increased mucin secretion in a concentration-dependent manner, with 0.01 to 1.0 µmol/L HNE increasing secretion significantly over vehicle control (Figure 1B)
.
|
Secretion of major gel-forming mucins, including MUC2, MUC5AC, and MUC5B, was investigated after exposure to HNE. As illustrated in Figure 2
, HNE enhanced release of both MUC5AC and MUC5B mucins from NHBE cells in a concentration-dependent manner. Secretion of MUC2 mucin was significantly decreased by HNE.
|
Elastatinal appeared to be the weakest of the three HNE inhibitors used in this study because the highest concentration used, 100 µmol/L, blocked only 50% of HNE enzymatic activity and did not affect HNE-stimulated mucin secretion (Figure 3A)
. CMK proved to be a more potent HNE enzymatic inhibitor because 50 µmol/L CMK completely blocked the enzymatic activity of 1 µmol/L HNE, whereas lower concentrations partially inhibited HNE activity in a concentration-dependent manner. CMK also showed an inhibitory effect on HNE-stimulated mucin secretion in a concentration-dependent manner with 50 µmol/L CMK almost completely blocking the secretory effect of HNE (Figure 3B)
. AT was the most potent HNE inhibitor among the three tested because 5 µmol/L AT blocked 90% of HNE enzymatic activity and completely inhibited its mucin-secretory effect (Figure 3C)
. Elastatinal (100 µmol/L), CMK (50 µmol/L), or AT (5 µmol/L) by themselves did not affect constitutive mucin secretion (data not shown). As illustrated in Figure 3D
, boiling HNE inactivated the enzyme rapidly: boiling for 5 minutes inhibited 70 to 80% HNE activity, while boiling for 15 minutes inhibited HNE activity. Interestingly, HNE boiled for 5 minutes still was able to induce mucin secretion, but boiling for 15 minutes abolished the ability of HNE to provoke mucin secretion.
|
, media collected from NHBE cell cultures exposed to HNE, called conditioned medium, was capable of stimulating mucin secretion when applied to a different set of NHBE cells. However, this effect was inhibited by AT, indicating that the secretory response was only due to the presence of HNE in the conditioned medium. Thus, effects of HNE on mucin secretion do not appear to involve a soluble secondary product released by NHBE cells.
|
As illustrated in Figure 5, A and B
, both PKC inhibitors, bisindolylmaleimide I and calphostin C, attenuated HNE-stimulated mucin secretion in a concentration-dependent manner.
|
As illustrated in Figure 5C
, exposure of NHBE cells to HNE caused a rapid (within 2 minutes) phosphorylation of MARCKS protein, reflecting activation of PKC.
PKC Isoforms in HNE-Induced Mucin Secretion
Western blot studies on cytosolic and membrane fractions of NHBE cells were performed under constitutive conditions and after stimulation with HNE (0.5 µmol/L) or a positive control, PMA (100 nmol/L). As illustrated in Figure 6
, PKC, , , , , and were expressed constitutively in nonstimulated NHBE cells, while PKCß and were induced in the cytosol and PKCµ in the membrane only after exposure to PMA. PKC or were not detected under any conditions. Of these isoforms, only PKC translocated from cytosol to membrane after HNE exposure (Figure 6)
. Preincubation of cells with rottlerin, a specific PKC inhibitor, for 20 minutes before HNE exposure resulted in reduction of total PKC activity and attenuation of HNE-induced mucin secretion (Figure 7)
. None of the other PKC isoform-specific inhibitors affected HNE-induced mucin secretion (data not shown).
|
|
|
Discussion |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
100 µg/ml).15,16
Interestingly, in studies related to mucin production in response to HNE, Voynow and colleagues40
showed that a much lower HNE concentration (25 nmol/L) can increase MUC5AC mRNA and protein expression in human airway epithelial cells. The majority of the secretion measurements in our study were done via an ELISA using the pan-mucin antibody, 17Q2, which is directed toward a carbohydrate epitope and therefore recognizes mucins derived from different MUC genes.41 It has been reported previously that HNE has an ability to release mucins from airway goblet cells and then to degrade the released mucins.9 However, because we measured pan-mucins using the 17Q2 antibody that recognizes carbohydrate epitope(s), it is very likely that the amount of mucins detected would be virtually the same regardless of the intactness of mucins. Therefore, degradation of mucins by the hydrolytic effects of HNE would not affect the results or the conclusion of this study.
The mucin proteins secreted in response to elastase appear to be a combination of the gene products of MUC5AC and MUC5B, as ELISA-based analysis revealed significant secretion of both mucins in response to HNE. MUC5AC mucin is usually considered to be the major mucin protein produced and secreted by airway epithelial cells, with MUC5B restricted mostly to submucosal glands.42,43 However, Chen and colleagues44 and Holmen and colleagues45 independently reported recently that cultured human airway epithelial cells express MUC5B, as does epithelium in situ in both human bronchitis and mouse models of asthma.44 Thus, MUC5B might also be a relevant mucin gene to investigate in relation to the pathogenesis of mucus overproduction and hypersecretion in inflammatory airway disease. MUC2 is not produced in large amounts by human airway epithelium under normal conditions, and the absolute amounts released in control or HNE-exposed cells were miniscule compared to MUC5AC or MUC5B. The statistically significant decrease in response to HNE could be the result of degradation, because the antibody is against the peptide core. Although it is possible that some degradation of MUC5AC and MUC5B also occurred in these experiments, it would be masked by the high levels of release of these proteins, whereas the effects on MUC2, already at low levels, would be observable. The story has become even more complicated with the recent description of a newly discovered respiratory mucin, MUC19, that also could be involved in inflammation-associated responses of the secretory apparatus in airways.46 The exact contribution(s) of each of these mucin genes to human airway mucin secretions in health and disease remains to be determined.
In the studies reported here, we found that the secretagogue activity of HNE was linked to its enzymatic activity. However, although complete inhibition of HNE activity also blocked HNE-induced mucin secretion (Figure 3)
, inhibition of HNE enzymatic activity by 50% [as caused by addition of 100 µmol/L elastatinal (Figure 3A)
, 5 µmol/L CMK (Figure 3B)
, or 0.5 µmol/L AT (Figure 3C)
] did not alter the secretory response, as the increase in mucin secretion by cultures in response to HNE that had been treated with any of these agents, and thus contained only approximately half of its original enzymatic activity, still reached the same levels as that induced by intact HNE. However, as indicated in Figure 1B
, 0.1 µmol/L of HNE had essentially the same effect on mucin secretion as 1.0 µmol/L, so the relationship between enzymatic activity and secretory stimulation does not appear direct, at least at the higher concentrations. It is possible that attenuation of enzymatic activity at lower concentrations of HNE could have had more of an effect on secretory activity. In any case, given that concentrations of HNE in airways of patients with airway inflammation can reach micromolar levels,15-17
potential anti-elastase therapy in such diseases might need to significantly diminish the enzymatic activity of HNE before it could become effective against its secretory action.
There is a possibility that a potential HNE-related product that acts as a secondary stimulus, rather than HNE directly, could be responsible for HNE-stimulated secretion. If this were true and the potential product(s) were soluble, then the product might be found in the conditioned medium from cells exposed to HNE, and this conditioned medium would induce mucin secretion if added to other cells in a manner such that an elastase inhibitor, such as AT, would not block the enhanced secretion if added directly to the conditioned medium. As illustrated in Figure 4
, AT did in fact inhibit conditioned medium-induced mucin secretion, suggesting that a soluble product released on HNE exposure was not involved. Of course, a soluble product could be released and bind rapidly to the NHBE cells, so these results do not preclude the existence of secondary mediators in the secretory response to HNE. These findings also do not preclude either an HNE substrate or HNE cleavage product that could influence secretion being present on epithelial cell membranes (or even intracellularly). In this regard, Takeyama and colleagues19
have reported that contact between neutrophils and epithelial cells enhances neutrophil chemoattractant-stimulated goblet cell degranulation, and Kim and colleagues9
suggested that HNE binding to epithelial cell surfaces maximized its stimulatory activity.
Whatever the actual stimulatory product, be it HNE directly or a secondary product, the secretory response appears to be mediated by PKC. The PKC family contains three types of isoforms: classical (cPKCs: , ß1, ß2, ), novel (nPKCs: , , , , µ), and atypical (aPKCs: , /). The classical isoforms are calcium- and phorbol ester-activated, the novel are calcium-insensitive but activated by phorbol esters, and the atypical isoforms are both calcium- and phorbol ester-insensitive, with all isoforms activated by phosphatidylserine.46
Our studies demonstrating that human tracheal epithelial cells express , ß1, ß2, , , and isoforms of PKC are in general agreement with previous reports.47-49
Involvement of PKC in secretion of airway mucin in response to various stimuli has been indicated previously.50-55
The specific PKC isoenzyme(s) (singly or in combination) that contribute to PKC-induced mucin secretion have not been determined, although PKC and PKC have been suggested as potential candidates.50,53,54
In our studies with HNE, both the DAG-binding site inhibitor of PKC (calphostin C) and the ATP-binding site inhibitor (bisindolylmaleimide I) blocked mucin release in concentration-dependent manners, suggesting that a cPKC or nPKC isoform(s) is involved in the secretory response. When we examined translocation of PKC isoforms in response to HNE, the only isoform that moved from cytoplasm to membrane in NHBE cells exposed to stimulatory concentrations of HNE was PKC (Figure 6)
. When NHBE cells then were exposed to PKC isoform-specific pharmacological inhibitors, the only inhibitor that attenuated secretion was rottlerin, which also appeared to attenuate enhancement of PKC activity in cells exposed to HNE (Figure 7)
. Further verification of the involvement of the PKC isoform in the secretory process using molecular constructs, such as dominant-negative PKC, siRNA, and so forth, would be valuable, but at this time problems with transfection of these constructs into primary cells and the presence of a heterogeneous cell population in NHBE cultures make these kinds of studies difficult to perform.
As illustrated in Figure 6
, there were effects of PMA and HNE on expression of other isoforms of PKC. For example, in response to PMA, PKCß appeared in the cytosol and PKCµ appeared in the membrane fraction, whereas neither isoform appeared to be expressed constitutively. PMA also caused an apparent decrease of protein expression of PKC in the cytosolic fraction. Since these blots were performed within 15 minutes of exposure, there is little if any probability that transcription could have occurred. There are (at least) two possible explanations for these responses. Firstly, they could reflect rapid posttranscriptional and/or translational events. Secondly, PMA is known to bind to PKCs in the C1 regulatory domain of the enzyme, and it is possible that such binding could induce conformational changes that could expose previously masked epitopes, or, in the case of PKC, block access of an antibody to such epitopes. Relatedly, PKC expression in the membrane fraction appeared to be decreased after exposure to HNE, and it could be that HNE effects on membranes, alluded to previously, could affect expression of several membrane proteins, including some PKC isoforms. In any case, these alterations in expression of several isoforms require further study to determine the mechanisms of action of PMA and/or HNE.
The involvement of PKC in the secretory response to HNE is interesting in light of recent findings that this particular PKC isoform has a number of potentially important functions in airway epithelial cell pathophysiology. These include regulation of nuclear factor-
B-dependent expression of proinflammatory genes in a human airway epithelial cell line,47
control of both NKCC1 function and Na-K-2Cl co-transport in airway epithelial cells,49,56
and regulation of asbestos-induced apoptosis in alveolar epithelial cells.57
Interestingly, Abdullah and colleagues50
reported that mucin secretion in response to purinergic stimulation in SPOC1 cells, a rat airway cell line, also may involve activation of PKC. In addition, a recent report implicated PKC in HNE-induced mucin gene expression in airway epithelium.58
A role for PKC in mucin secretion fits in nicely with previous studies from our laboratory showing that MARCKS protein, a widely expressed PKC phosphorylation target, is a key molecule regulating mucin secretion in airway epithelium,21,59
as PKC is activated by PMA and can phosphorylate MARCKS protein. Interestingly, as illustrated in Figure 5C
, MARCKS is rapidly phosphorylated when HNE is added to NHBE cells, but is quickly dephosphorylated. This pattern of phosphorylation-dephosphorylation of MARCKS was shown in a previous report from this laboratory to be a critical step in the mucin secretory pathway after stimulation21
so these results are consistent with previous studies implicating MARCKS protein in airway mucin secretion. Whether or not the secretagogue action of HNE depends on MARCKS, as shown with other stimuli that enhance mucin secretion, presently is under study, and if so would provide additional information supporting the existence of a common intracellular secretory pathway involving MARCKS present in goblet cells in response to a variety of pathophysiological stimuli in the airways.
|
Footnotes |
|---|
Supported by the National Institutes of Health (grant R37 HL36982 to K.B.A.).
Present address of F.H.: Allergan, Inc., P.O. Box 19534, Irvine CA 92623; present address of Y.L.: Tanox, Inc., 10301 Stella Link, Ste. 110, Houston, TX 77025.
Accepted for publication May 18, 2005.
|
References |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
 |
|
 |
|
  W.-C. Chung, S.-H. Ryu, H. Sun, D. C. Zeldin, and J. S. Koo CREB Mediates Prostaglandin F2{alpha}-Induced MUC5AC Overexpression J. Immunol., February 15, 2009; 182(4): 2349 - 2356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Voynow and B. K. Rubin Mucins, Mucus, and Sputum Chest, February 1, 2009; 135(2): 505 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Moghaddam, C. G. Clement, M. M. De la Garza, X. Zou, E. L. Travis, H. W. J. Young, C. M. Evans, M. J. Tuvim, and B. F. Dickey Haemophilus influenzae Lysate Induces Aspects of the Chronic Obstructive Pulmonary Disease Phenotype Am. J. Respir. Cell Mol. Biol., June 1, 2008; 38(6): 629 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Pantano, J. L. Ather, J. F. Alcorn, M. E. Poynter, A. L. Brown, A. S. Guala, S. L. Beuschel, G. B. Allen, L. A. Whittaker, M. Bevelander, et al. Nuclear Factor-{kappa}B Activation in Airway Epithelium Induces Inflammation and Hyperresponsiveness Am. J. Respir. Crit. Care Med., May 1, 2008; 177(9): 959 - 969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kraft, K. B. Adler, J. L. Ingram, A. L. Crews, T. P. Atkinson, C. B. Cairns, D. C. Krause, and H. W. Chu Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma Eur. Respir. J., January 1, 2008; 31(1): 43 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Kuwahara, E. P. Lillehoj, T. Koga, Y. Isohama, T. Miyata, and K. C. Kim The Signaling Pathway Involved in Neutrophil Elastase Stimulated MUC1 Transcription Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 691 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-A. Park, A. L. Crews, W. R. Lampe, S. Fang, J. Park, and K. B. Adler Protein Kinase C{delta} Regulates Airway Mucin Secretion via Phosphorylation of MARCKS Protein Am. J. Pathol., December 1, 2007; 171(6): 1822 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cheng, Z. Shao, B. Chaudhari, and D. K. Agrawal Involvement of chloride channels in TGF-beta1-induced apoptosis of human bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1339 - L1347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-W. Kim, J. S. Hong, S.-H. Ryu, W.-C. Chung, J.-H. Yoon, and J. S. Koo Regulation of Mucin Gene Expression by CREB via a Nonclassical Retinoic Acid Signaling Pathway Mol. Cell. Biol., October 1, 2007; 27(19): 6933 - 6947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Abdullah and C. W. Davis Regulation of airway goblet cell mucin secretion by tyrosine phosphorylation signaling pathways Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L591 - L599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. LeSimple, I. van Seuningen, M.-P. Buisine, M.-C. Copin, M. Hinz, W. Hoffmann, R. Hajj, S. L. Brody, C. Coraux, and E. Puchelle Trefoil Factor Family 3 Peptide Promotes Human Airway Epithelial Ciliated Cell Differentiation Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 296 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Yuan-chen Wu, R. Wu, S. P. Reddy, Y. C. Lee, and M. M.-J. Chang Distinctive Epidermal Growth Factor Receptor/Extracellular Regulated Kinase-Independent and -Dependent Signaling Pathways in the Induction of Airway Mucin 5B and Mucin 5AC Expression by Phorbol 12-Myristate 13-Acetate Am. J. Pathol., January 1, 2007; 170(1): 20 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Finzi, V. Barbu, P.-R. Burgel, M. Mergey, K. S. Kirkwood, E. C. Wick, J.-Y. Scoazec, F. Peschaud, F. Paye, J. A. Nadel, et al. MUC5AC, a Gel-Forming Mucin Accumulating in Gallstone Disease, Is Overproduced via an Epidermal Growth Factor Receptor Pathway in the Human Gallbladder Am. J. Pathol., December 1, 2006; 169(6): 2031 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Kuwahara, E. P. Lillehoj, W. Lu, I. S. Singh, Y. Isohama, T. Miyata, and K. C. Kim Neutrophil elastase induces IL-8 gene transcription and protein release through p38/NF-{kappa}B activation via EGFR transactivation in a lung epithelial cell line Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L407 - L416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Takashi, J. Park, S. Fang, S. Koyama, I. Parikh, and K. B. Adler A Peptide Against the N-Terminus of Myristoylated Alanine-Rich C Kinase Substrate Inhibits Degranulation of Human Leukocytes In Vitro Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 647 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. N. Chorley, Y. Li, S. Fang, J.-A. Park, and K. B. Adler (R)-Albuterol Elicits Antiinflammatory Effects in Human Airway Epithelial Cells via iNOS Am. J. Respir. Cell Mol. Biol., January 1, 2006; 34(1): 119 - 127. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
, significantly less than vehicle control (P < 0.05). Data are presented as mean ± SEM (n = 6 at each point).
, Significantly different from vehicle control (P < 0.001). , Significantly different from HNE alone (P < 0.05). Data are presented as mean ± SEM (n = 12 at each point).
